D-β-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease

Journal of Neuroscience Research

Volumn 84, Issue 6, 2006, Pages 1376-1384

  Imamura, Keiko ^a   Takeshima, Takao ^a   Kashiwaya, Yoshihiro ^b   Nakaso, Kazuhiro ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

AlamarBlue; Caspase; Ketone body; LDH; Mitochondria

Indexed keywords

3 HYDROXYBUTYRIC ACID; 3 NITROPROPIONIC ACID; CASPASE 3; CASPASE 9; KETONE BODY; LACTATE DEHYDROGENASE; ROTENONE;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL;

3-HYDROXYBUTYRIC ACID; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; FLUORESCENT DYES; HUMANS; INDOLES; KETONE BODIES; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; NEURONS; NEUROTOXINS; NITRO COMPOUNDS; OXIDATION-REDUCTION; PARKINSON DISEASE, SECONDARY; PROPIONIC ACIDS; ROTENONE; SUCCINATES; UNCOUPLING AGENTS;

EID: 33750465828     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21021     Document Type: Article

References (41)

1. Alam M, Schmidt WJ. 2002. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317-324.
2. Alston TA, Mela L, Bright HJ. 1977. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci U S A 74:3767-3771.
3. Auestad N, Korsak RA, Morrow JW, Edmond J. 1991. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 56:1376-1386.
4. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.
5. Bixel MG, Hamprecht B. 1995. Generation of ketone bodies from leucine by cultured astroglial cells. J Neurochem 65:2450-2461.
6. Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F, Palfi S, Hantraye P. 1998. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794-805.
7. Chance B, Ernster L, Garland PB, Lee CP, Light PA, Ohnishi T, Ragan CI, Wong D. 1967. Flavoproteins of the mitochondrial respiratory chain. Proc Natl Acad Sci U S A 57:1498-1505.
8. Chen X, Tsukaguchi H, Chen XZ, Berger UV, Hediger MA. 1999. Molecular and functional analysis of SDCT2, a novel rat sodium-dependent dicarboxylate transporter. J Clin Invest 103:1159-1168.
9. Cooper JM, Daniel SE, Marsden CD, Schapira AH. 1995. L- dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain. Mov Disord 10:295-297.
10. Decker T, Lohmann-Matthes ML. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61-69.
11. Fields RD, Lancaster MV. 1993. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab 11:48-50.
12. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. 1998. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102:1358-1363.
13. Friedrich T, van Heek P, Leif H, Ohnishi T, Forche E, Kunze B, Jansen R, Trowitzsch-Kienast W, Hofle G, Reichenbach H. 1994. Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase. Eur J Biochem 219:691-698.
14. Gonzalez RJ, Tarloff JB. 2001. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol In Vitro 15:257-259.
15. Gould DH, Gustine DL. 1982. Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid. Neuropathol Appl Neurobiol 8:377-393.
16. Kashiwaya Y, King MT, Veech RL. 1997. Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart. Am J Cardiol 80:50A-64A.
17. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. 2000. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 97:5440-5444.
18. Korzeniewski C, Callewaert DM. 1983. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313-320.
19. Lambert MP, Stevens G, Sabo S, Barber K, Wang G, Wade W, Krafft G, Snyder S, Holzman TF, Klein WL. 1994. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J Neurosci Res 39:377-385.
20. Lang AE, Lozano AM. 1998. Parkinson's disease. First of two parts. N Engl J Med 339:1044-1053.
21. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
22. Masuda R. Monahan JW, Kashiwaya Y. 2005. D-beta-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J Neurosci Res 80:501-509.
23. Mattson MP. 2000. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120-129.
24. McGarry JD, Foster DW. 1980. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49:395-420.
25. Mizuno Y, Hattori N, Matsumine H. 1998. Neurochemical and neurogenetic correlates of Parkinson's disease. J Neurochem 71:893-902.
26. Nakaso K, Nakamura C, Sato H, Imamura K, Takeshima T, Nakashima K. 2006. Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-denved induction of antioxidative proteins. Biochem Biophys Res Commun 339:915-922.
27. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. 1967. Brain metabolism during fasting. J Clin Invest 46:1589-1595.
28. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T. 1984. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14:135-144.
29. Foot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL, Haugland RP. 1996. Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 44:1363-1372.
30. Ross RA, Spengler BA, Biedler JL. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. JNCI 71:741-747.
31. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. 1995. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 9:651-658.
32. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54:823-827.
33. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. 2003. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23:10756-10764.
34. Sims NR, Anderson MF. 2002. Mitochondrial contributions to tissue damage in stroke. Neurochem Int 40:511-526.
35. Springer JE, Azbill RD, Carlson SL. 1998. A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue. Brain Res Brain Res Protoc 2:259-263.
36. Takeshima T, Johnston JM, Commissiong JW. 1994. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 14:4769-4779.
37. Veech RL, Kashiwaya Y, Gates DN, King MT, Clarke K. 2002. The energetics of ion distribution: the origin of the resting electric potential of cells. IUBMB Life 54:241-252.
38. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, Shinnar S, Shuman R, Trevathan E, Wheless JW. 1998. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 55:1433-1437.
39. White MJ, DiCaprio MJ, Greenberg DA. 1996. Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures. J Neurosci Methods 70:195-200.
40. Wilhamson DH, Lund P, Krebs HA. 1967. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103:514-527.
41. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.